Melanotan II
Marketed online for tanning without sun exposure, but carries serious safety risks including potential links to skin cancer. We strongly recommend discussing safer alternatives with a dermatologist.
This peptide is not FDA-approved for any indication. Human use outside of clinical trials is not recommended.
The basics
- Generic Name
- melanotan II
- Brand Names
- None (not an approved product)
- Regulatory Status
- Early Research
- Therapeutic Areas
- Endocrine
Wellness Goals
Important: This peptide is not yet FDA-approved
Melanotan II has not been approved by the FDA for any use in humans. That means it hasn't gone through the rigorous testing process that confirms a drug is safe and effective. Products sold online have not been evaluated by any regulatory body.
Heads up: The FDA has flagged some safety concerns with this one. That doesn't mean it's definitely dangerous, but it means we don't know enough yet.
What it does
Melanotan II (melanotan II) is a synthetic peptide that researchers are studying, but it's not yet FDA-approved for any human use. Synthetic analog of alpha-melanocyte-stimulating hormone that stimulates melanin production, causing skin darkening. Also has effects on sexual arousal and appetite.
The research is still early. Most studies so far are in animals or lab settings, so we don't know for sure how well this translates to real-world results in people.
How it's taken
Subcutaneous injection
Nasal spray (lower absorption)
How people access it
Only available through unregulated online vendors. Not FDA-approved and carries significant safety risks including potential links to melanoma. We do not recommend this peptide through any source.
Regulatory Status
Not FDA-approved. Carries significant safety concerns including links to melanoma. Not recommended.
FDA Safety-Risk Designation
This substance appears on the FDA's list of substances that may present significant safety risks when used in compounding. This designation indicates that the FDA has identified concerns about the safety of this substance that have not been adequately addressed through clinical testing.
Any use in humans outside of an FDA-authorized clinical trial would require an Investigational New Drug (IND) application. Products marketed as “for research use only” are not legally intended for human administration.
What the Evidence Shows
The evidence base for Melanotan II consists primarily of preclinical studies (animal models and in vitro experiments). There are no completed, large-scale, peer-reviewed clinical trials establishing safety or efficacy in humans. The gap between promising animal data and proven human benefit is substantial — many compounds that show effects in animal studies fail to demonstrate safety or efficacy in human trials.
Marketing claims made by online sellers and “peptide clinics” frequently overstate the evidence and omit critical information about risks and unknowns.
Other options to consider
Depending on what you're hoping to achieve, there may be FDA-approved treatments that have been rigorously tested and proven to work. Discuss evidence-based options with your own healthcare provider to find what fits your specific goals.
Browse our full peptide directory to see FDA-approved options that might work for you.
Common Questions
Dermatologists strongly advise against using Melanotan II. It's not FDA-approved, and there are concerns about its potential link to melanoma and other skin issues. Safer tanning alternatives like self-tanners exist without these risks.
People are attracted to the idea of getting a tan without UV exposure. But the reality is more complicated — Melanotan II has unpredictable effects on skin pigmentation, can cause nausea and other side effects, and the long-term safety profile is unknown.
Yes. Self-tanning products (DHA-based) provide a cosmetic tan without any of the risks of injectable peptides or UV exposure. If you're concerned about vitamin D, talk to your doctor about supplementation rather than tanning.
Curious about what IS approved?
Check out FDA-approved peptides that address similar goals — with established safety profiles and real clinical evidence.
See Approved Options